Delivery Order SPE2DB22D3501-SPE2DB24FWB70

Award Date 6/25/24
Potential Completion Date 7/17/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $20,908.66 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of POLIVY 140 mg vials, a specialty pharmaceutical product. The contract has an ultimate completion date of August 21, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including prescription drugs, medical supplies, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,092.12 firm fixed-price delivery order is for the supply of POLIVY 140 MG VIALS, a pharmaceutical product, with a period of performance through July 3, 2025. The contract is not set-aside and was awarded on June 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,092.12, is for the delivery of POLIVY 140 MG VIALS. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 21, 2025. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564288200 POLIVY 140 MG VIALS to the U.S. government. The contract, valued at $40,304.38, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is a Delivery Order valued at $20,908.66 for the supply of POLIVY 140 MG VIALS. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen for pharmaceutical and medical products. Amerisourcebergen is a large pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
This federal contract award, valued at $10,454.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of POLIVY 140 MG VIALS, a pharmaceutical product, with a completion date of January 29, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $90,574.48 firm fixed-price delivery order is for the supply of POLIVY 140 MG VIALS, a pharmaceutical product. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,046.06, is a Firm Fixed Price Delivery Order to provide POLIVY 140 MG VIALS to support military healthcare programs. The contract has an ultimate completion date of March 17, 2025 and was awarded on February 24, 2025. This award is not designated as a set-aside contract. Amerisourcebergen...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide POLIVY 140 MG VIALS. The award has a potential value of $20,908.66 and a completion date of March 25, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award and has previously received numerous...
This is a firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of POLIVY 140 MG VIALS, a medical product, with a ceiling value of $55,115.15 and a completion date of June 3, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWB70
    Delivery Order

This federal contract award, valued at $20,908.66, was granted to AmerisourceBergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) on June 25, 2024. The contract is a delivery order for the supply of 140 mg vials of the drug POLIVY, with a completion date of July 17, 2024.

AmerisourceBergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award is a specific order against this larger IDC contract. No set-aside designation was used for this procurement.

Generated 9/24/24, 9:32 AM